Denali Therapeutics Inc. (DNLI)

Import this data to Google Sheets with:

=jivedata("DNLI","financials")

Full statements spill as a table. For one cell: =jivedata("DNLI","Revenue") or =jivedata("DNLI","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Denali Therapeutics Inc.

DNLI • CIK 0001714899

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$330,531	$0	$0	$3,604
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal	—	$14,537	$0	$0
Operating Income (Loss)	$-196,699	$-487,341	$-555,342	$-542,697
Interest and Other Income	—	$64,636	$42,904	$31,348
Income (Loss) Attributable to Parent, before Tax	$-145,194	$-422,705	$-512,438	$-512,438
Income Tax Expense (Benefit)	$30	$68	$102	$102
Net Income (Loss) Attributable to Parent	$-145,224	$-422,773	$-512,540	$-511,451
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-137,695	$-421,396	$-513,878	$-514,359
Weighted Average Number of Shares Outstanding, Basic	137,370,897	164,473,772	172,649,097	188,290,141
Research and Development Expense	$423,876	$396,440	$418,778	$400,720
General and Administrative Expense	$103,354	$105,438	$136,564	$140,722
Operating Expenses	$527,230	$501,878	$555,342	$547,119
OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax	$7,529	$1,377	$-1,338	$-2,908

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$127,106	$174,960	$205,326	$201,530
Marketable Securities, Current	$907,405	$657,371	$662,553	$508,941
Marketable Securities, Noncurrent	—	$359,373	$98,322	$229,534
Prepaid Expense and Other Assets, Current	$29,626	$32,105	$32,779	$35,390
Property, Plant and Equipment, Net	$45,589	$55,236	$52,402	$49,926
Assets, Current	$1,064,137	$864,436	$900,658	$753,927
Finance Lease, Right-of-Use Asset, after Accumulated Amortization	—	$47,533	$48,531	$46,700
Operating Lease, Right-of-Use Asset	$26,048	$22,861	$19,002	$16,793
Other Assets, Noncurrent	$18,143	$24,741	$25,939	$25,825
Assets	$1,153,917	$1,374,180	$1,144,854	$1,157,955
Operating Lease, Liability, Noncurrent	$44,981	$36,673	$27,210	$22,026
Finance Lease, Liability, Noncurrent	—	$5,615	$5,532	$5,479
Liabilities	$122,963	$144,496	$131,093	$322,777
Accounts Payable, Current	$9,483	$11,137	$3,330	$11,807
Accrued Liabilities, Current	$68,499	$91,071	$95,021	$78,276
Liabilities, Current	$77,982	$102,208	$98,351	$90,083
Preferred Stock, Value, Outstanding	—	$0	$0	$0
Common Stock, Value, Outstanding	—	$1,768	$1,888	$1,924
Additional Paid in Capital	$2,144,811	$2,764,880	$3,062,715	$3,142,747
Accumulated Other Comprehensive Income (Loss), Net of Tax	$643	$2,020	$682	$-1,969
Retained Earnings (Accumulated Deficit)	$-1,116,211	$-1,538,984	$-2,051,524	$-2,307,524
Stockholders' Equity Attributable to Parent	$1,030,954	$1,229,684	$1,013,761	$835,178
Preferred Stock, Shares Authorized	40,000,000	40,000,000	40,000,000	40,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	400,000,000	400,000,000	400,000,000	400,000,000
Common Stock, Shares, Issued	138,385,498	144,220,986	156,182,177	159,755,526
Accounts and Other Receivables, Net, Current	$3,420	$2,171	$2,177	$2,177
Property, Plant and Equipment, Gross	$91,592	$107,278	$115,297	$115,297
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$46,003	$52,042	$62,895	$62,895
Depreciation, Depletion and Amortization	$16,726	$7,795	$11,183	$6,414
Employee-related Liabilities, Current	$21,590	$24,728	$32,179	$13,424
Operating Lease, Liability, Current	$7,260	$8,308	$9,463	$10,084
Finance Lease, Liability, Current	—	$3,726	$83	$97

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-90,863	$47,854	$31,897	$60,323
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$128,681	$176,535	$208,432	$539,111
Net Income (Loss) Attributable to Parent	$-145,224	$-422,773	$-512,540	$-511,451
Net Cash Provided by (Used in) Operating Activities	$-357,991	$-347,694	$-412,600	$-434,040
Proceeds from Sale and Maturity of Marketable Securities	$2,075,947	$1,157,120	$706,046	$799,113
Payments to Acquire Marketable Securities	$1,813,700	$1,229,964	$441,263	$697,916
Payments to Acquire Property, Plant, and Equipment	$12,939	$15,912	$9,502	$3,417
Net Cash Provided by (Used in) Investing Activities	$249,308	$-88,756	$255,281	$68,980
Proceeds from Issuance of Common Stock	$0	$0	—	—
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised	$17,820	$17,389	$8,459	$25,507
Finance Lease, Principal Payments	—	$32,338	$8,168	$1,415
Payments of Financing Costs	—	—	$324	$324
Net Cash Provided by (Used in) Financing Activities	$17,820	$484,304	$189,216	$425,383
Noncash or Part Noncash Divestiture, Amount of Consideration Received	—	$15,000	$0	$0
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability	—	$9,358	$0	$0
Capital Expenditures Incurred but Not yet Paid	$553	$1,192	$0	$0
Finance Lease, Interest Payment on Liability	—	$302	$720	$720
Income Taxes Paid, Net	$3	$0	$46	$46
Depreciation, Depletion and Amortization	$16,726	$7,795	$11,183	$12,227
Share-based Payment Arrangement, Noncash Expense	$108,102	$102,878	$99,633	$95,088
Investment Income, Amortization of Discount	—	$35,117	$10,253	$6,372
Finance Lease, Right-of-Use Asset, Amortization	—	$1,197	$3,629	$3,662
Gain (Loss) on Disposition of Assets	—	$14,537	$0	$0
Other Noncash Income (Expense)	$-2	$0	$-49	$174
Increase (Decrease) in Prepaid Expense and Other Assets	$4,094	$2,480	$540	$-497
Increase (Decrease) in Other Noncurrent Assets	—	$-603	$-772	$2,554
Increase (Decrease) in Accounts Payable	$2,431	$1,437	$-7,520	$-3,375
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities	$2,648	$17,377	$465	$-4,491
Increase (Decrease) in Other Noncurrent Liabilities	$-379	$0	$0	$0
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs	$1,060	$480	$728	$728

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("DNLI","financials")

Full statements spill as a table. For one cell: =jivedata("DNLI","Revenue") or =jivedata("DNLI","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.